Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Sep 22
Love0

Long-Term Efficacy and Safety of Omalizumab Monotherapy in a Patient With Normocomplementemic Urticarial Vasculitis

By Chuck Lin No Comments
INTRODUCTIONNormocomplementemic urticarial vasculitis (NUV), a rare disease of long duration, presents with long-lasting wheals that show histopathologic features of vasculitis including leukocytoclasia, fibrin deposits, and extravasated erythrocytes.1,2,3 The musculoskeletal, respiratory,…
Read More
Sep 22
Love0

Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials

By Chuck Lin No Comments
INTRODUCTIONPlaque psoriasis and atopic dermatitis (AD) are chronic, immune-mediated skin diseases associated with a high burden of disease as well as a reduced quality of life.1 Although multiple options are…
Read More
Sep 15
Love0

A Retrospective Study of Calcinosis Cutis in Patients With Systemic Lupus Erythematosus

By Chuck Lin No Comments
INTRODUCTIONCalcinosis cutis (CC) is a very rare and poorly characterized finding in systemic lupus erythematosus (SLE).1 In this retrospective study, we present our experience of 10 individuals with SLE who…
Read More
Sep 15
Love0

A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis

By Chuck Lin No Comments
INTRODUCTIONDermatomyositis (DM) is an autoimmune myopathy with characteristic dermatologic features.1 Tofacitinib is an immunomodulator with proven efficacy against numerous immune-mediated disorders, including rheumatoid arthritis (RA) and psoriasis.2 Several reports have…
Read More
Sep 02
Love0

Reconstructing the Glabella and Nasal Root

By Chuck Lin No Comments
INTRODUCTIONReconstructive OptionsSecond Intention Second intention (granulation) is an option for smaller glabellar and nasal root defects given the concave nature. Larger defects require closure to avoid atrophic or hypertrophic scarring,…
Read More
Sep 02
Love0

Perioral Rejuvenation: Evaluation of Safety and Efficacy of High Molecular Weight Hyaluronic Acid and Amino Acid Treatment

By Chuck Lin No Comments
INTRODUCTIONThe lips and perioral area play a crucial role in facial aesthetics.1 Signs of aging, such as wrinkles, reduced muscle tone, and thinning skin, frequently appear first in this anatomical…
Read More
Sep 02
Love0

Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens

By Chuck Lin No Comments
INTRODUCTIONRosacea is a common relapsing facial skin condition most prevalent in Caucasian women from the Northern hemisphere, although this is likely due to reporting bias.1,2 Historically, rosacea has been considered…
Read More
Sep 01
Love0

Bullous Pemphigoid and Scabies: Is There an Association?

By Chuck Lin No Comments
INTRODUCTIONBullous pemphigoid (BP) is one of the most common autoimmune bullous diseases. It typically affects the elderly.1 It is characterized by autoantibodies against the basement membrane zone proteins- BP antigen…
Read More
Sep 01
Love0

The Role of Hormone Therapy in Female Aesthetic Rejuvenation

By Chuck Lin No Comments
INTRODUCTIONThe World Health Organization defines health as a state of complete physical, mental, and social well-being, and not merely the absence of disease or infirmity.1 This holistic definition of health…
Read More
Sep 01
Love0

Efficacy and Tolerability of a Retinoid Eye Cream for Fine to Moderate Wrinkles of the Periorbital Region

By Chuck Lin No Comments
INTRODUCTIONThinner than other regions of the face, possessing fewer oil glands, and subject to repetitive contractions, skin around the eyes is particularly susceptible to environmental factors and accelerated skin aging.1-5…
Read More
Sep 01
Love0

Systemic Medications Associated With Hair Texture Changes

By Chuck Lin No Comments
INTRODUCTIONWhile chemotherapy-induced alopecia is one of the most well-known medication adverse effects (having an estimated incidence of 65%),1 numerous reports suggest that hair structure can be more subtly altered by…
Read More
Aug 31
Love0

FULL SUPPLEMENT: THE ROLE OF EPIDERMAL BARRIER DYSFUNCTION AND CUTANEOUS MICROBIOME DYSBIOSIS IN THE PATHOGENESIS AND MANAGEMENT OF ACNE VULGARIS AND ROSACEA

By Chuck Lin No Comments
In this supplement:Dysbiosis, (Barrier) Dysfunction, and Dermatoses: A Chicken-and-Egg Dilemma Acne vulgaris (AV) and rosacea are two of the most common dermatoses diagnosed and managed by dermatologists.1,2 Despite this and…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Benjamin Button Effect: Recognizable Rejuvenation June 17, 2025
  • Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis June 16, 2025
  • Practical Algorithm on Topical Treatment of Flaring Atopic Dermatitis (AD) With or Without Secondary Infection June 13, 2025
  • Acne Awareness Month June 12, 2025
  • The Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market June 11, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search